Compounds > pirinixic acid

Page last updated: 2024-11-05

pirinixic acid and Adenocarcinoma Of Kidney

pirinixic acid has been researched along with Adenocarcinoma Of Kidney in 1 studies

pirinixic acid: structure

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Wang, R	3
Zhao, J	3
Jin, J	3
Tian, Y	3
Lan, L	3
Wang, X	3
Zhu, L	3
Wang, J	3

Other Studies

1 other study available for pirinixic acid and Adenocarcinoma Of Kidney

Article	Year
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC. Lipids in health and disease, 2022, Nov-16, Volume: 21, Issue:1 Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm	2022
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC. Lipids in health and disease, 2022, Nov-16, Volume: 21, Issue:1 Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm	2022
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC. Lipids in health and disease, 2022, Nov-16, Volume: 21, Issue:1 Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm	2022
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC. Lipids in health and disease, 2022, Nov-16, Volume: 21, Issue:1 Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm	2022
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC. Lipids in health and disease, 2022, Nov-16, Volume: 21, Issue:1 Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm	2022
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC. Lipids in health and disease, 2022, Nov-16, Volume: 21, Issue:1 Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm	2022
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC. Lipids in health and disease, 2022, Nov-16, Volume: 21, Issue:1 Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm	2022
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC. Lipids in health and disease, 2022, Nov-16, Volume: 21, Issue:1 Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm	2022
WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC. Lipids in health and disease, 2022, Nov-16, Volume: 21, Issue:1 Topics: Carcinoma, Renal Cell; Carnitine O-Palmitoyltransferase; Cell Proliferation; Humans; Kidney Neoplasm	2022